Mark van Oene
Geschäftsführer bei PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Mark van Oene
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Geschäftsführer | 08.01.2021 | - |
Illumina Cambridge Ltd.
Illumina Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
BlueGnome Ltd.
BlueGnome Ltd. Packaged SoftwareTechnology Services BlueGnome Ltd. provides application software services. It offers solutions for detection of copy number variation in the human genome. The firm's main application areas include analysis of constitutional samples to elucidate genetic disease, investigation of haematological malignancies and aneuploidy screening of single cells. The company was founded on October 15, 2001 and is headquartered in Saffron Walden, the United Kingdom. | Direktor/Vorstandsmitglied | 22.01.2018 | - |
Dante Labs, Inc.
Dante Labs, Inc. Medical/Nursing ServicesHealth Services Dante Labs, Inc. operates as a genetic testing laboratory. The company was founded by Andrea Riposati and Mattia Capulli in 2016 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 24.08.2021 | - |
Karriereverlauf von Mark van Oene
Ehemalige bekannte Positionen von Mark van Oene
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ellipsis Biotherapeutics Corp.
Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Corporate Officer/Principal | - | - |
ILLUMINA, INC. | Corporate Officer/Principal | 01.01.2014 | - |
Vertrieb & Marketing | 01.01.2012 | 01.01.2014 |
Ausbildung von Mark van Oene
University of Western Ontario | Undergraduate Degree |
University of Toronto | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Kanada | 4 |
Vereinigtes Königreich | 3 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Sales & Marketing | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ILLUMINA, INC. | Health Technology |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Illumina Cambridge Ltd.
Illumina Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom. | Commercial Services |
BlueGnome Ltd.
BlueGnome Ltd. Packaged SoftwareTechnology Services BlueGnome Ltd. provides application software services. It offers solutions for detection of copy number variation in the human genome. The firm's main application areas include analysis of constitutional samples to elucidate genetic disease, investigation of haematological malignancies and aneuploidy screening of single cells. The company was founded on October 15, 2001 and is headquartered in Saffron Walden, the United Kingdom. | Technology Services |
Ellipsis Biotherapeutics Corp.
Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Commercial Services |
Dante Labs, Inc.
Dante Labs, Inc. Medical/Nursing ServicesHealth Services Dante Labs, Inc. operates as a genetic testing laboratory. The company was founded by Andrea Riposati and Mattia Capulli in 2016 and is headquartered in New York, NY. | Health Services |
- Börse
- Insiders
- Mark van Oene
- Erfahrung